GNOM (STOCKS)
Global X Genomics & Biotechnology ETF
$45.811400
+0.400800 (+0.88%)
Prev close: $45.410600
Company Information
- Exchange
- XNAS
- Sector
- Miscellaneous
- Industry
- Investment Trusts Or Mutual Funds
- CEO
- —
- Asset Type
- stocks
- Website
- —
Fundamentals
- Market Cap
- $50.15M
- Employees
- —
- P/E (TTM)
- -20.86
- P/B (TTM)
- 3.69
- Dividend Yield
- 25.39%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $22.35M |
| Benefits Costs and Expenses | $98.78M |
| Cost Of Revenue | $28.07M |
| Costs And Expenses | $98.78M |
| Gross Profit | -$5.73M |
| Operating Expenses | $70.71M |
| Research and Development | $34.82M |
| Other Operating Expenses | $24.18M |
| Operating Income/Loss | -$76.43M |
| Income/Loss From Continuing Operations After Tax | -$79.37M |
| Income/Loss From Continuing Operations Before Tax | -$76.43M |
| Interest Expense, Operating | $2.96M |
| Net Income/Loss | -$79.37M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$79.37M |
| Net Income/Loss Available To Common Stockholders, Basic | -$79.37M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $80.82M |
| Current Assets | $48.30M |
| Inventory | $6.76M |
| Prepaid Expenses | $1.33M |
| Other Current Assets | $40.20M |
| Noncurrent Assets | $32.53M |
| Fixed Assets | $31.39M |
| Other Non-current Assets | $1.13M |
| Liabilities | $48.38M |
| Current Liabilities | $45.48M |
| Accounts Payable | $4.97M |
| Wages | $2.04M |
| Other Current Liabilities | $38.47M |
| Noncurrent Liabilities | $2.90M |
| Long-term Debt | $22.54M |
| Equity | $32.44M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $32.44M |
| Liabilities And Equity | $80.82M |
| Net Cash Flow From Operating Activities | -$60.39M |
| Net Cash Flow From Operating Activities, Continuing | -$60.39M |
| Net Cash Flow From Investing Activities | $25.93M |
| Net Cash Flow From Investing Activities, Continuing | $25.93M |
| Net Cash Flow From Financing Activities | $4.27M |
| Net Cash Flow From Financing Activities, Continuing | $4.27M |
| Net Cash Flow | -$30.20M |
| Net Cash Flow, Continuing | -$30.20M |
| Comprehensive Income/Loss | -$79.37M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$79.37M |
| Other Comprehensive Income/Loss | -$7.02M |